We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genotyping Test Evaluated for Human Papilloma Virus

By LabMedica International staff writers
Posted on 10 Jan 2011
A genotyping test kit has been evaluated for identifying human papilloma virus (HPV) in histological tissue samples. More...


A Linear Array HPV test kit identifies, and then specifically genotypes the virus in formalin-fixed, paraffin-embedded (FFPE) tissues from head and neck cancer patients.

In a study performed at Dartmouth Medical School, (Lebanon, NH, USA), scientists evaluated the performance of Roche Linear Array HPV Genotyping test kit assay (F. Hoffmann-La Roche AG, Basel, Switzerland), for accuracy, for intra-assay and interassay precision, and for its limit of detection, using materials with known HPV status. DNA from formalin-fixed, paraffin-embedded tumor sections was isolated and amplified in duplicate, with positive and negative controls, using primers specific to the polymorphic L1 region of the HPV genome.

Thirty-seven genotypes were tested using the linear array. The amplified product (450 base pairs) was visualized by gel electrophoresis and, if positive, reflexed to HPV genotyping. Of these cases, all were determined to have suitable DNA for genotyping based on an internal control gene reaction. The Linear Array HPV Genotyping kit contains positive β-globin high-control and β-globin low-control bands for determining whether the DNA from FFPE tissue is suitable for HPV genotyping using this assay. Nine of the 16 tumors analyzed were HPV positive. The detected genotypes included HPV 6, 16, and 69.

Head and neck tumors commonly arise from the squamous and respiratory mucosa that lines the nasal and oral cavity, sinuses, pharynx, and larynx. The rate of oropharyngeal cancers diagnosed among Americans younger than 50 years is increasing. Infection of the oropharynx and tonsils by the human papillomavirus (HPV) has been linked to preneoplasia and cancer.

The Roche Linear Array HPV Genotyping test was found to be an easy-to-use method for determining HPV genotype in the routine analysis of formalin-fixed, paraffin-embedded tumors. According to the authors, this assay was robust and can be performed routinely in a clinical laboratory setting. The study was published in December 2010, in the Archives of Pathology & Laboratory Medicine.

Related Links:

Dartmouth Medical School
F. Hoffmann-La Roche



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Manual Pipetting Aid
Pipette Controllers macro
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.